Starting #obesity treatment with drugs seems like a good idea. Considering surgery as soon as it stops working is even better. Ricardo Cohen IFSO Paulina Salminen IFSO LAC IFSO-EC The Lancet Diabetes & Endocrinology sciencedirect.com/science/articl…

Para mis colegas IFSO LAC y Sociedad Española de Cirugía de la Obesidad invitación en español IFSO

Great meta-analysis on weight recurrence trajectory after stopping weight loss medications 👇👇👇

Dr. Midhat Abu Sneineh has just returned from his Observership with Prof. catalin copaescu at Ponderas Academic Hospital, Bucharest, Romania. One more happy surgeon who took advantage of the IFSO Observership Program 2025! 👨‍⚕️✨ #IFSO #OBSERVERSHIP #ifsoobservershipprogram

Did you know that genetics play a role in Obesity? First evidence was provided by family, twin and adoption studies that have estimated heritability rates for Obesity to be up to 70%.

Best time to take care of Obesity is now, with many evidence-based therapies and combination approaches ASMBS IFSO North America Chapter Intuitive Boston Scientific Medtronic Eli Lilly and Company Novo Nordisk ReShape Lifesciences Johnson & Johnson Johnson & Johnson MedTech

“25 years later, I’m still grateful I chose bariatric surgery.” Listen to Helen’s story ... #IFSO #MBS #bariatricsurgery #weightloss

⏳ Just 1 month to go! IFSO 2025 is coming to Santiago and we can’t wait to see you there! Haven’t registered yet? Secure your spot today at 🔗ifso2025.org #IFSO2025 #IFSO2025SANTIAGO

“This journey didn’t just help me lose weight — it saved my life.” At just 27 years old, Katrina had already spent years struggling with her weight and worsening health. Four years ago, she chose bariatric surgery — and everything changed. #bariatricsurgery #PatientStories

ASMBS has secured our seat in the AMA House of Delegates through 2030, and the timing could not be more important! Learn more here: buff.ly/nURroi3 #ASMBS #BariatricSurgery #MetabolicHealth #Healthcare #ObesityCare #ObesityTreatment #Obesity #ChronicDisease #Health

IFSO 2025 Santiago SCOPINARO LECTURE: "A Miracle that moved the World" #IFSO2025 #IFSO2025SANTIAGO 🔗ifso2025.org

The Lancet Commission definition on clinical obesity and its meaning for metabolic and bariatric surgery. Out today. IFSO Francesco Rubino Ted Kyle link.springer.com/content/pdf/10…

For a man with obesity, would you recommend the initiation of semaglutide therapy or bariatric and metabolic surgery? Read the case vignette and essays on both treatment options and cast your vote: nej.md/3HiAnJz

Semaglutide (Wegovy®) has been approved for treatment of MASH fda.gov/drugs/news-eve… ASMBS ASMBS IH IFSO IFSO North America Chapter

Treating patients with Obesity + T2DM is always more challenging ☑️ STEP 2 trial (Semaglutide only): 9.6% WL ☑️ SURMOUNT 2 trial (Tirzepatide only): 14.7% WL ☑️ REDEFINE 2 trial 👇(Semaglutide + Cagrlinitide): 13.7% WL ASMBS ASMBS IH IFSO IFSO North America Chapter

CagriSema phase 3 trial 20.4% weight loss ASMBS IFSO ASMBS IH IFSO North America Chapter

Excess fat in the body can accumulate in the liver, leading to a condition known as non-alcoholic fatty liver disease (NAFLD). Metabolic Bariatric Surgery is one of the few proven treatments that can halt and even reverse advanced stages of fatty liver disease. #bariatricsurgery

"From BMI to Disease Diagnosis: What Clinical and Pre‑clinical Obesity Mean for Surgeons" Read the article: link.springer.com/article/10.100… Download the pdf: ifso.com/pdf/clinical-a…

This is a great statement and simple to follow understanding the need to offer therapies for risk reduction vs treatment